Does Kaiser Permanente Cover Dupixent?
The verdict
Covered on most plans
Kaiser Permanente covers Dupixent on its closed formulary with prior authorization and step therapy, prescribed and dispensed entirely within the Kaiser integrated system. Because Kaiser is its own insurer, prescriber network, and pharmacy, the PA is internal and there is no external specialty-pharmacy choice. Cost-share follows the member's Kaiser plan; the $2,100 (2026) Part D cap applies to Kaiser Medicare members. Verify tier and step-therapy details within your specific Kaiser plan.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Kaiser Permanente using your member ID.
Key facts
Kaiser Permanente operates a closed integrated model — the insurer, the physician network, and the specialty pharmacy are all one organization, meaning Dupixent PA and dispensing are handled entirely within Kaiser with no external PBM or specialty pharmacy.
Kaiser Permanente — integrated health model information
Dupixent (dupilumab) is FDA-approved for six indications: atopic dermatitis (age 6 months+), moderate-to-severe asthma (age 6+), chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, and COPD with eosinophilic phenotype.
FDA drug labeling — Dupixent (dupilumab), Sanofi/Regeneron
The 2026 Medicare Part D out-of-pocket cap is $2,100; Kaiser Senior Advantage Part D members who reach this threshold pay $0 for covered drugs for the rest of the calendar year.
CMS.gov — Medicare Part D benefit parameters 2026
Medicare vs. commercial coverage
Whether Kaiser Permanente covers Dupixent depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Kaiser Senior Advantage Part D plans: Dupixent is on Kaiser's formulary with PA and step therapy. Members pay approximately 25-33% coinsurance after the deductible, capped at $2,100 for 2026 — the plan covers 100% of cost above that cap. Per Sanofi/Regeneron, about 79% of Medicare Part D Dupixent recipients pay $0-$100 per month under post-IRA catastrophic protections. Dispensing is through Kaiser's own specialty pharmacy; no external specialty-pharmacy option. The Dupixent MyWay copay card is not available to Medicare beneficiaries. When Dupixent is administered in a Kaiser clinical setting, it may be billed under Medicare Part B (medical benefit) rather than Part D.
Commercial / Employer
Group & marketplace plans
Commercial/Employer (Kaiser HMO) plans: Dupixent is on Kaiser's closed formulary with internal PA and indication-specific step therapy; plan cost-share (copay or coinsurance) per member's Kaiser plan. You must see a Kaiser allergist, dermatologist, pulmonologist, or gastroenterologist to initiate the PA — Kaiser does not accept referrals for PA from out-of-network providers in its standard HMO model. The drug is dispensed by Kaiser's own specialty pharmacy. ACA/Individual marketplace Kaiser plans cover Dupixent with PA where offered on the closed formulary. Medicaid (Kaiser Medi-Cal/managed-care): covered for approved indications per contract with PA; nominal cost-share. Medical vs. pharmacy benefit: primarily pharmacy-benefit self-injected via Kaiser pharmacy; can shift to Part B/medical benefit when administered in a Kaiser clinic. The Dupixent MyWay copay card's usability within Kaiser's closed model is not confirmed — verify with Kaiser member services before relying on it.
The 5 boxes you must tick to get approved
Commercial plans that will consider Dupixent require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Dupixent actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Approximately $3,993 per carton of 2 pre-filled pens (list price, Jan 2025 estimate); average retail approximately $5,350-$5,377 per month (estimate). Treat all cash figures as estimates — verify current pricing before use.
List price with no coverage — before any manufacturer savings card.
With coverage
Kaiser plan cost-share per member's specific Kaiser plan design (copay or coinsurance). Kaiser Medicare (Senior Advantage Part D): approximately 25-33% coinsurance after deductible, capped at $2,100 for 2026. Commercial: plan-specific copay or coinsurance — refer to your Kaiser Evidence of Coverage. Medicaid: nominal cost-share.
Typical monthly copay once prior authorization is approved.
Bridge program
Dupixent MyWay copay program (Sanofi/Regeneron): available to eligible commercially insured patients at as little as $0 per month. Usability within Kaiser's closed dispensing model is NOT confirmed — verify with Kaiser member services before assuming the card applies. Not available to Medicare or Medicaid beneficiaries.
Reduced copay through the assistance program, where eligible.
Kaiser's closed integrated model means cost-share is set entirely by your Kaiser plan documents. Do not assume external specialty-tier coinsurance ranges apply. Verify exact cost on your Kaiser Evidence of Coverage or by contacting Kaiser member services.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Contact your Kaiser specialist or request a referral to Kaiser's allergy/dermatology/pulmonology department
In Kaiser's integrated model, coverage verification and PA initiation both happen internally. Ask your primary care physician for a referral to the appropriate Kaiser specialist (allergist, dermatologist, pulmonologist, or gastroenterologist depending on your indication). The specialist verifies that Dupixent is on the Kaiser formulary for your indication and initiates the PA.
- 2
Have the Kaiser specialist complete the internal Prior Authorization
Your Kaiser specialist submits the PA through Kaiser's internal clinical system — no external PBM portal is involved. The clinical team documents diagnosis, prior treatment history, disease severity, and supporting lab values. Because PA is internal, the process is typically less bureaucratically complex than external PBM submissions, but you must be treated within the Kaiser system.
- 3
Pick up or arrange home delivery through Kaiser's specialty pharmacy
After PA approval, Kaiser's specialty pharmacy dispenses Dupixent — either for in-office pick-up or home delivery, depending on your Kaiser region and plan. There is no option to use an outside specialty pharmacy. If you are a Medicare member, understand that the $2,100 (2026) Part D cap limits your total annual drug cost-share once it is reached.
Options if Kaiser Permanente won't cover Dupixent
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Topical corticosteroids and calcineurin inhibitors
For atopic dermatitis: required step-therapy agents within Kaiser's formulary protocols before Dupixent. Kaiser's specialist will document failure or contraindication as part of the internal PA.
Xolair (omalizumab), Nucala (mepolizumab), Tezspire (tezepelumab)
For asthma: Kaiser's internal formulary protocols may require trials of preferred asthma biologics before Dupixent, depending on phenotype. Confirm the required step-therapy sequence with your Kaiser pulmonologist or allergist.
Rinvoq (upadacitinib) — JAK inhibitor (atopic dermatitis)
Kaiser's internal formulary guidance for moderate-to-severe atopic dermatitis may include a JAK inhibitor trial before Dupixent for adult patients. Discuss with your Kaiser dermatologist whether this applies to your care plan.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Yes, Kaiser Permanente covers Dupixent on its closed formulary with prior authorization and step therapy, prescribed by a Kaiser specialist and dispensed through Kaiser's own specialty pharmacy. There is no option to use an outside specialty pharmacy while in-network. Coverage follows the member's Kaiser plan design; for Medicare members, the $2,100 (2026) Part D cap applies.
Kaiser's integrated model means everything is internal: your specialist, the PA process, and the specialty pharmacy are all Kaiser. You do not navigate an external PBM like Express Scripts or OptumRx. This reduces administrative complexity, but also means you must be seen by Kaiser specialists and use Kaiser's pharmacy. If you prefer an out-of-network specialist or pharmacy, Kaiser's HMO model generally will not cover those services.
Cost-share is set by your specific Kaiser plan documents (copay or coinsurance). For Kaiser Medicare Senior Advantage Part D members, coinsurance is approximately 25-33% after the deductible, capped at $2,100 for 2026 — after which you pay nothing for covered drugs for the rest of the year. About 79% of Medicare Part D Dupixent recipients pay $0-$100 per month per Sanofi/Regeneron. For commercial Kaiser HMO plans, refer to your Evidence of Coverage for the specialty-drug cost-share.
The Dupixent MyWay copay card is designed for commercially insured patients and is not available to Medicare or Medicaid enrollees. Its usability within Kaiser's closed dispensing system is not confirmed — some closed-model plans do not process manufacturer copay cards at their in-house pharmacies. Verify with Kaiser member services before assuming the card will apply to your cost-share.
Dupixent is primarily dispensed as a self-injected pharmacy-benefit drug through Kaiser's specialty pharmacy. However, when administered in a Kaiser clinical setting by a healthcare provider, coverage can shift to the medical benefit — billed under Part B for Medicare members or under the medical cost-share for commercial plans. Most Kaiser members receive Dupixent as a home self-injection under the pharmacy benefit.
Related Articles
Does Kaiser Permanente Cover Vyvanse? | Curex
Kaiser Permanente covers Vyvanse on its closed formulary via Kaiser pharmacies — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL.
Read moreDoes Kaiser Permanente Cover Qsymia? 2026 | Curex
Kaiser's closed HMO limits Qsymia access; Medi-Cal excluded weight-loss drugs in 2026. Engage cash program ~$89/mo; generic launched 2025.
Read moreDoes Kaiser Permanente Cover Cialis? 2026 | Curex
Kaiser Permanente does not cover Cialis for ED — Medicare Part D bars it by law and commercial plans exclude it. Generic tadalafil IS covered for BPH.
Read moreDoes Kaiser Permanente Cover Jardiance? 2026
Kaiser Permanente covers Jardiance on its closed-network formulary for T2D. Metformin-first step may apply. 2026 MFP $197; $2,100 cap for Medicare.
Read moreDoes Kaiser Permanente Cover Ozempic? 2026 Guide | Curex
Kaiser NW covers Ozempic for T2D — requires metformin plus SGLT-2 step therapy, strictest in the cluster. Tier 3, closed network, weight-loss excluded.
Read moreDoes Kaiser Permanente Cover Viagra? 2026 Guide
Kaiser Permanente does not cover Viagra for ED. The Medicare Part D statutory exclusion applies. Only covered path: sildenafil (Revatio) for PAH.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Kaiser Permanente before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.